231 related articles for article (PubMed ID: 11050888)
1. [Insulin sensitizer. A new therapy option for type 2 diabetic patients].
Filz HP
MMW Fortschr Med; 2000 Sep; 142(38):31-3. PubMed ID: 11050888
[TBL] [Abstract][Full Text] [Related]
2. Thiazolidinediones for type 2 diabetes. New agents reduce insulin resistance but need long term clinical trials.
Krentz AJ; Bailey CJ; Melander A
BMJ; 2000 Jul; 321(7256):252-3. PubMed ID: 10915108
[No Abstract] [Full Text] [Related]
3. Differentiating members of the thiazolidinedione class: a focus on efficacy.
Goldstein BJ
Diabetes Metab Res Rev; 2002; 18 Suppl 2():S16-22. PubMed ID: 11921434
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance and its treatment by thiazolidinediones.
Lebovitz HE; Banerji MA
Recent Prog Horm Res; 2001; 56():265-94. PubMed ID: 11237217
[TBL] [Abstract][Full Text] [Related]
5. The glitazones: proceed with caution.
Krische D
West J Med; 2000 Jul; 173(1):54-7. PubMed ID: 10903299
[No Abstract] [Full Text] [Related]
6. Troglitazone: antihyperglycemic activity and potential role in the treatment of type 2 diabetes.
Scheen AJ; Lefèbvre PJ
Diabetes Care; 1999 Sep; 22(9):1568-77. PubMed ID: 10480527
[TBL] [Abstract][Full Text] [Related]
7. Troglitazone and related compounds: therapeutic potential beyond diabetes.
Fujiwara T; Horikoshi H
Life Sci; 2000 Oct; 67(20):2405-16. PubMed ID: 11065164
[TBL] [Abstract][Full Text] [Related]
8. [Combination therapy of insulin sensitizer, thiazolidinedione drugs, and sulfonylurea].
Ohmura E; Hosaka D; Imai Y; Kawazu S
Nihon Rinsho; 2002 Sep; 60 Suppl 9():470-5. PubMed ID: 12387036
[No Abstract] [Full Text] [Related]
9. [Thiazolidinediones: clinical data and perspectives].
Blicklé JF
Diabetes Metab; 2001 Apr; 27(2 Pt 2):279-85. PubMed ID: 11452222
[TBL] [Abstract][Full Text] [Related]
10. [Current status of the treatment of type 2 diabetes mellitus. The revival of insulin-resistance drugs].
Brogard JM; Neyrolles N; Andres E; Blicklé JF
Rev Med Interne; 1999 Aug; 20 Suppl 3():371s-378s. PubMed ID: 10480188
[TBL] [Abstract][Full Text] [Related]
11. Glitazones: clinical effects and molecular mechanisms.
Stumvoll M; Häring HU
Ann Med; 2002; 34(3):217-24. PubMed ID: 12173692
[TBL] [Abstract][Full Text] [Related]
12. Troglitazone in type II diabetes mellitus.
Sparano N; Seaton TL
Pharmacotherapy; 1998; 18(3):539-48. PubMed ID: 9620105
[TBL] [Abstract][Full Text] [Related]
13. Hepatotoxicity with thiazolidinediones: is it a class effect?
Scheen AJ
Drug Saf; 2001; 24(12):873-88. PubMed ID: 11735645
[TBL] [Abstract][Full Text] [Related]
14. A prospective, randomized comparison of the metabolic effects of pioglitazone or rosiglitazone in patients with type 2 diabetes who were previously treated with troglitazone.
Khan MA; St Peter JV; Xue JL
Diabetes Care; 2002 Apr; 25(4):708-11. PubMed ID: 11919129
[TBL] [Abstract][Full Text] [Related]
15. Switching insulin-sensitizing agents in patients with type 2 diabetes who require insulin.
Blonde L; Sandberg MI; Guthrie RD
Diabetes Care; 1999 Jun; 22(6):1004-6. PubMed ID: 10372262
[No Abstract] [Full Text] [Related]
16. Repaglinide in combination therapy.
Moses R
Diabetes Nutr Metab; 2002 Dec; 15(6 Suppl):33-8. PubMed ID: 12702006
[TBL] [Abstract][Full Text] [Related]
17. Troglitazone: a review of its use in the management of type 2 diabetes mellitus.
Plosker GL; Faulds D
Drugs; 1999 Mar; 57(3):409-38. PubMed ID: 10193691
[TBL] [Abstract][Full Text] [Related]
18. Troglitazone add-on therapy to a combination of sulfonylureas plus metformin achieved and sustained effective diabetes control.
Gavin LA; Barth J; Arnold D; Shaw R
Endocr Pract; 2000; 6(4):305-10. PubMed ID: 11242607
[TBL] [Abstract][Full Text] [Related]
19. Troglitazone: the discovery and development of a novel therapy for the treatment of Type 2 diabetes mellitus.
Parker JC
Adv Drug Deliv Rev; 2002 Nov; 54(9):1173-97. PubMed ID: 12393300
[TBL] [Abstract][Full Text] [Related]
20. New diabetes drug targets insulin resistance.
Am J Health Syst Pharm; 1997 Mar; 54(6):623, 625. PubMed ID: 9075488
[No Abstract] [Full Text] [Related]
[Next] [New Search]